Immunolight, LLC

As we reflect on this year, we’re grateful for the progress made in the fight against cancer and the support of our incredible community. Together, we’re moving closer to breakthroughs and brighter tomorrows. Wishing you a season filled with hope, joy, and good health!

What do the following items have in common? A) Lipstick B) Semiconductor Chips C) Athletic Shoes D) Solar Panels They all can be enhanced using Immunolight’s energy conversion technology! Using the energy converters innovated by Immunolight, each of these items can be made with enhanced colors, more efficient production and/or improved operation. And all have been the subject of patents obtained by Immunolight in 2024! US Patents 11,901,331; 11,964,167; 11, 998,760; and 12,076,579 – just a few examples from the Immunolight portfolio covering non-medical uses of the Immunolight energy conversion technology. Check it out! #innovation #immunolight

We at Immunolight are grateful for the dedication of our team, the trust of our patients, and the support of our partners. Together, we are making strides in clinical research and improving lives.

Unfortunately, the FiRe 2024 Conference in Palos Verdes, California has been rescheduled for next Spring due to the ongoing landslides in the area.  We will keep you posted as more information becomes available on the rescheduled date and location.  Our sympathies go out to all of those affected by this situation.

Unite with us this month as we support all those that have been impacted by breast cancer! We are dedicated to researching a better treatment to help those battling breast cancer. Immunolight Cancer Therapy (ICT) is currently in a Phase 1 Clinical Trial and recruiting patients - Click the link in our bio to learn more!

Tune into the FiRe podcast interview with Berit Anderson, FiRe COO, and Harold Walder, President of Immunolight, as they discuss Immunolight Cancer Therapy (ICT), its development, how the treatment is delivered, and what lies ahead for Immunolight at the upcoming 2024 FiRe Conference this October. #FiRe2024 #Immunolight #Cancer #ClinicalTrials See link to the podcast in the comments

A new chapter begins! We are thrilled to announce that our groundbreaking cancer treatment, formerly known as X-PACT, is now Immunolight Cancer Therapy (ICT). This new name reflects our commitment to light-based innovation and marks a significant milestone in our mission to provide advanced and effective treatments for cancer patients. #cancer #clinicaltrials #sarcoma #breastcancer

Join us this Sarcoma Awareness Month as we stand strong with those battling sarcoma. Together, we're committed to advancing research, providing hope, and supporting every patient on their journey. Immunolight is currently running a Phase 1 Clinical Trial for ICT (Immunolight Cancer Therapy), click the link in our bio to learn more! 💛 #SarcomaAwareness #StrongerTogether #CancerTreatment

We're excited to announce that Immunolight has been selected as one of twelve start-up companies to be featured as a presenter at the prestigious 2024 Future in Review Conference (FiRe). Chosen as the innovative company in the field of medicine for the development of our revolutionary cancer treatment, we are honored and thrilled to announce this recognition. We look forward to sharing our latest advancements and engaging with today’s thought leaders in science and technology! Learn more about the Future in Review . Learn more about Immunolight, LLC and our non-chemo clinical research. #FutureinReview #TechLeadership #PalosVerdes #Cancer #ClinicalTrials

Sunday recognized #WorldCancerDay, let's stand together in support of those fighting, honor the survivors, remember the taken, and continue to strive for better treatments and a cure. Together, we can make a difference. 💪🎗️ #FightCancer #WorldCancerDay2024